103 related articles for article (PubMed ID: 25026028)
1. Expression of CD55 on red blood cells of β-thalassemia patients.
Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
Hemoglobin; 2014; 38(5):339-44. PubMed ID: 25026028
[TBL] [Abstract][Full Text] [Related]
2. Compensation of CD55 Underexpression on Red Blood Cells of β-Thalassemia Major Patients.
Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
Hemoglobin; 2015; 39(3):184-9. PubMed ID: 25897480
[TBL] [Abstract][Full Text] [Related]
3. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
[TBL] [Abstract][Full Text] [Related]
4. The effects of marathon running on expression of the complement regulatory proteins CD55 (DAF) and CD59 (MACIF) on red blood cells.
Simpson RJ; Florida-James GD; Whyte GP; Middleton N; Shave R; George K; Guy K
Eur J Appl Physiol; 2007 Jan; 99(2):201-4. PubMed ID: 17089158
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Complement Regulatory Proteins CD55 and CD59 on Erythrocytes in Beta-Thalassemia Major Patients.
Zahran AM; Shaltout AS; Hamada IH; Mohammed AM; Abo Elgheet AM; Elsayh KI
Egypt J Immunol; 2020 Jan; 27(1):109-118. PubMed ID: 33180393
[TBL] [Abstract][Full Text] [Related]
6. Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection.
Terpos E; Sarantopoulos A; Kouramba A; Katsarou O; Stavropoulos J; Masouridi S; Karafoulidou A; Meletis J
Med Sci Monit; 2008 May; 14(5):CR276-280. PubMed ID: 18443552
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of CD55 and CD59 on red blood cells in sickle cell disease.
Al-Faris L; Al-Rukhayes M; Al-Humood S
Hematology; 2017 Mar; 22(2):105-113. PubMed ID: 27667587
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of different flow cytometry-based immunophenotypic methods for the analysis of CD59 and CD55 expression on major peripheral blood cell subsets.
Hernández-Campo PM; Martín-Ayuso M; Almeida J; López A; Orfao A
Cytometry; 2002 Jun; 50(3):191-201. PubMed ID: 12116342
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients.
Alegretti AP; Mucenic T; Merzoni J; Faulhaber GA; Silla LM; Xavier RM
Cell Immunol; 2010; 265(2):127-32. PubMed ID: 20727519
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD55, CD59, and CD35 on red blood cells of β-thalassaemia patients.
Kurtoǧllu AU; Koçtekin B; Kurtoǧlu E; Yildiz M; Bozkurt S
Cent Eur J Immunol; 2017; 42(1):78-84. PubMed ID: 28680334
[TBL] [Abstract][Full Text] [Related]
12. The effect of splenectomy on complement regulatory proteins in erythrocytes in β-thalassemia major.
Kurtoğllu AU; Koçtekin B; Kurtoğlu E; Yildiz M
Arch Med Sci; 2019 Jan; 15(1):191-195. PubMed ID: 30697270
[TBL] [Abstract][Full Text] [Related]
13. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
Nuutila J; Jalava-Karvinen P; Hohenthal U; Kotilainen P; Pelliniemi TT; Nikoskelainen J; Lilius EM
Hum Immunol; 2013 May; 74(5):522-30. PubMed ID: 23376460
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of CD55 and CD59 expression on reticulocytes and mature erythrocytes in paroxysmal nocturnal hemoglobinuria, aplastic anemia, and healthy control subjects.
Kim Y; Lim J; Kim M; Kim Y; Lee JW; Han K
Ann Clin Lab Sci; 2010; 40(3):226-32. PubMed ID: 20689133
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of erythrocytes in paroxysmal nocturnal hemoglobinuria reveals superiority of CD59 as a diagnostic marker compared to CD55.
Tembhare P; Ramani M; Syed K; Gupta AD
Indian J Pathol Microbiol; 2010; 53(4):699-703. PubMed ID: 21045396
[TBL] [Abstract][Full Text] [Related]
16. Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes.
Christmas SE; de la Mata Espinosa CT; Halliday D; Buxton CA; Cummerson JA; Johnson PM
Immunology; 2006 Dec; 119(4):522-8. PubMed ID: 16999828
[TBL] [Abstract][Full Text] [Related]
17. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
Ziller F; Macor P; Bulla R; Sblattero D; Marzari R; Tedesco F
Eur J Immunol; 2005 Jul; 35(7):2175-83. PubMed ID: 15971270
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the free α-hemoglobin pool in red blood cells: a new test providing a scale of β-thalassemia severity.
Vasseur C; Pissard S; Domingues-Hamdi E; Marden MC; Galactéros F; Baudin-Creuza V
Am J Hematol; 2011 Feb; 86(2):199-202. PubMed ID: 21264907
[TBL] [Abstract][Full Text] [Related]
19. Altered Expression Pattern of CD55 and CD59 on Red Blood Cells in Anemia of Chronic Kidney Disease.
Al-Faris L; Al-Humood S; Behbehani F; Sallam H
Med Princ Pract; 2017; 26(6):516-522. PubMed ID: 28957817
[TBL] [Abstract][Full Text] [Related]
20. Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer.
Shang Y; Chai N; Gu Y; Ding L; Yang Y; Zhou J; Ren G; Hao X; Fan D; Wu K; Nie Y
Arch Pathol Lab Med; 2014 Jul; 138(7):910-9. PubMed ID: 24978917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
